Mode
Text Size
Log in / Sign up
N/A N=15 Prevention

Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH)

Cardiovascular Diseases · Infant ALL · Maternal Behavior · Childhood Obesity

Enrolled (actual)
15
Serious AEs
0.0%
Results posted
May 2025
Primary outcome: Primary: Feasibility of Integration of a Cardiovascular Health Module Into the Existing Nurse-Family Partnership (NFP) Home Visiting Program. — 14 participants receiving intervention

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Infant Cardiovascular Health (CVH) Promotion (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Penn State University
Primary completion
Jun 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Feasibility of Integration of a Cardiovascular Health Module Into the Existing Nurse-Family Partnership (NFP) Home Visiting Program.
14
SECONDARY
Number of Mothers Consenting for Their Infants to Participate in the Pilot Study.
15
SECONDARY
Utility of Infant Foot Worn Actigraphy Device for Infant Sleep Data Collection.
SECONDARY
Number of Participants Completing Maternal Feeding Data Collection
SECONDARY
Participant Intervention Acceptability.

Summary

This pilot study aims to examine the feasibility and acceptability of adding a cardiovascular health module to the existing Nurse Family Partnership (NFP) home visitation program delivered by trained nurses in the Northern Appalachian region of Central Pennsylvania.

Eligibility Criteria

Inclusion Criteria

  • Mother-infant dyad enrolled in and receiving the Nurse Family Partnership program through one of the study teams community partner offices throughout Central Pennsylvania
  • Mother age ≥ 18 years at time of delivery
  • Mother English speaking
  • Singleton infant born at ≥ 35 weeks' gestation
  • Infant age < 1 month at time of consent
  • Mother with reliable access to the internet for consent and data collection purposes

Exclusion Criteria

  • Unable or unwilling to comply with the study visits and procedures.
  • Participation in a concurrent intervention study.
  • Infants with known chromosomal abnormalities, complex congenital heart disease, or birth defects inconsistent with survival to age 2 years.
  • Infant with substantial feeding difficulty (e.g., those requiring tube feeding)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05824741). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search